Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1064P is a **pseudogene** transcribed as "RNA, U6 small nuclear 1064, pseudogene," denoted as RNU6-1064P[1]. This pseudogene is a non-functional copy of the U6 small nuclear RNA gene family, which encodes components of the spliceosomal machinery in its functional forms. As a pseudogene, RNU6-1064P does **not encode a functional protein or RNA product** and is not known to serve as a direct therapeutic target, receptor, enzyme, transporter, or biomarker[1]. While some pseudogenes elsewhere in the genome have regulatory functions, such as acting as competing endogenous RNAs or producing small regulatory RNAs, there is currently **no evidence that RNU6-1064P plays any known biological or disease role in humans**[1][3][4]. **Note:** Pseudogenes may sometimes play indirect roles in gene regulation and have been linked to regulatory networks in cancer and other diseases[3], but RNU6-1064P is not cataloged as having such a function, and is not considered a therapeutic target. Its biological significance, if any, is presently uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1064, pseudogene (RNU6-1064P).